| pubmed-article:9680930 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9680930 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:9680930 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:9680930 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:9680930 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:9680930 | lifeskim:mentions | umls-concept:C0027481 | lld:lifeskim |
| pubmed-article:9680930 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:9680930 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9680930 | pubmed:dateCreated | 1998-8-18 | lld:pubmed |
| pubmed-article:9680930 | pubmed:abstractText | We studied serum N-terminal atrial natriuretic peptide (NT-ANP) in children during and after chemotherapy for cancer to determine its applicability in detecting cardiac dysfunction. Forty-three patients were receiving chemotherapy for malignancy. Forty-eight patients were off chemotherapy and survived between 0.9 and 13 (median 5) years after the diagnosis, receiving cumulative anthracycline doses between 0 and 600 (median 225) mg/m2. | lld:pubmed |
| pubmed-article:9680930 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9680930 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9680930 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9680930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9680930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9680930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9680930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9680930 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9680930 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9680930 | pubmed:issn | 0098-1532 | lld:pubmed |
| pubmed-article:9680930 | pubmed:author | pubmed-author:PerkkiöMM | lld:pubmed |
| pubmed-article:9680930 | pubmed:author | pubmed-author:HeleniusTT | lld:pubmed |
| pubmed-article:9680930 | pubmed:author | pubmed-author:RiikonenPP | lld:pubmed |
| pubmed-article:9680930 | pubmed:author | pubmed-author:TikanojaTT | lld:pubmed |
| pubmed-article:9680930 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9680930 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:9680930 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9680930 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9680930 | pubmed:pagination | 73-8 | lld:pubmed |
| pubmed-article:9680930 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:meshHeading | pubmed-meshheading:9680930-... | lld:pubmed |
| pubmed-article:9680930 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9680930 | pubmed:articleTitle | Serum N-terminal atrial natriuretic peptide (NT-ANP) in the cardiac follow-up in children with cancer. | lld:pubmed |
| pubmed-article:9680930 | pubmed:affiliation | Department of Pediatrics, Kuopio University Hospital, Finland. Tero.Tikanoja@kuh.fi | lld:pubmed |
| pubmed-article:9680930 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9680930 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
